Health & Life Co., Ltd. (TPEX:1781)
Taiwan · Delayed Price · Currency is TWD 10.75
-0.10 (-0.92%)
Aug 26, 2026, 1:30 PM CST
Health & Life Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 400.09 | 398.05 | 706.39 | 601.17 | 797.54 | 811.88 |
Revenue Growth | -30.90% | -43.65% | 17.50% | -24.62% | -1.77% | 4.87% |
Gross Profit Gross Profit Growth | 54.88 | 70.12 | 147.74 | 93.11 | 97.73 | 45.76 |
Operating Income Operating Income Growth | -75.04 | -63.41 | 2.5 | -41.06 | -44.39 | -96.89 |
Net Income Net Income Growth | -50.67 | -61.67 | 24.24 | -33.23 | -17.55 | -62.34 |
Earnings Per Share EPS Growth | -1.07 | -1.30 | 0.48 | -0.70 | -0.37 | -1.31 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Others Others Growth | 9.68 | 4.65 | 324.87 | 282.35 | 230.07 |
Northeast Asia Northeast Asia Growth | 58.75 | 100.53 | 68.86 | 119.89 | 133.53 |
Europe Europe Growth | 9.24 | 11.56 | 38.26 | 45.87 | 65.69 |
America America Growth | 320.37 | 589.65 | - | - | - |
Total Total Growth | 398.05 | 706.39 | 601.17 | 797.54 | 811.88 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 222.42 | 247.65 | 277.02 | 150.72 | 156.64 | 200.01 |
Total Debt Total Debt Growth | 197.97 | 196.85 | 214.01 | 113.48 | 189.28 | 134.65 |
Net Cash (Debt) Net Cash Growth | 24.45 | 50.8 | 63.01 | 37.24 | -32.64 | 65.37 |
Net Cash Growth | -28.27% | -19.38% | 69.22% | - | - | -70.23% |
Net Cash Per Share Net Cash Per Share Growth | 0.52 | 1.07 | 1.25 | 0.79 | -0.69 | 1.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -16.59 | 3.18 | 33.39 | 84.91 | -80.7 | -131.15 |
Capital Expenditures CapEx Growth | -7.78 | -6.92 | -2.74 | -7.97 | -4.74 | -12.38 |
Free Cash Flow Free Cash Flow Growth | -24.37 | -3.74 | 30.65 | 76.94 | -85.44 | -143.53 |
Free Cash Flow Growth | - | - | -60.16% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 13.72% | 17.61% | 20.91% | 15.49% | 12.25% | 5.64% |
Operating Margin | -18.75% | -15.93% | 0.35% | -6.83% | -5.56% | -11.93% |
Pretax Margin | -12.23% | -16.92% | 4.07% | -6.25% | -1.94% | -10.26% |
Profit Margin | -12.66% | -15.49% | 3.43% | -5.53% | -2.20% | -7.68% |
FCF Margin | -6.09% | -0.94% | 4.34% | 12.80% | -10.71% | -17.68% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 35.11 | - | - | - |
P/FCF Ratio | - | - | 27.76 | 10.44 | - | - |
PS Ratio | 1.29 | 1.32 | 1.21 | 1.34 | 0.91 | 0.91 |